New approach to managing warfarin patients improves care, cuts costs

January 10, 2017

New performance measures have been developed for patients on warfarin that may save lives and money.

Warfarin is a commonly prescribed anticoagulant (blood thinner) used by millions of Americans to treat or prevent blood clots and/or strokes. Warfarin management can be measured by the proportion of time patients spend in the therapeutic range—the range in which they are protected from and not at excessive risk of bleeding.

Previous research has shown that hospitals and physician offices vary in terms of how skillfully they manage their patients on this drug. Researchers from Boston University School of Medicine (BUSM) have now developed several performance measures intended to help hospitals and clinicians improve the management of warfarin in their patients. These findings appear in the Annals of Pharmacotherapy.

Patients on warfarin in the eight medical centers in the VA's New England region were compared to receiving warfarin in other parts of the country. "Patients who used these measures did better clinically than those in the control group," explained corresponding author Adam Rose, MD, associate professor of medicine at BUSM.

According to the researchers while previous studies have intervened to improve warfarin management at a single site or practice, this is the first such study to improve care across an entire health network.

"This study serves as a model for how other sites and health networks could feasibly approach improving the management of warfarin in their systems. If all anticoagulation clinics in the VA were to achieve this level of improvement, it would prevent 48 strokes and 68 major bleeding events each year, with a savings to the VA system of more than $4 million annually," he added.

Rose believes that if a similar approach were adopted by other large health systems, there could also be improvement of patient outcomes and savings due to averted adverse events. "Insufficient attention has been given in the past to how we can improve the of ; this study demonstrates that a relatively simple approach can have a large impact."

Explore further: Medication adherence a problem in atrial fibrillation patients

Related Stories

Medication adherence a problem in atrial fibrillation patients

January 4, 2017
For patients with atrial fibrillation, the most common form of heart arrhythmia, a main goal of treatment is stroke prevention.

Atrial fibrillation patients are at increased risk of dementia, regardless of anticoagulation use

November 15, 2016
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial ...

Physician-perceived frailty tied to warfarin discontinuation

August 17, 2016
(HealthDay)—Physician-perceived frailty and low life expectancy are the main reasons for warfarin discontinuation in elderly patients, according to a study published online July 29 in the Journal of Thrombosis and Haemostasis.

PPI cuts risk of warfarin-related upper GI bleeding

December 23, 2016
(HealthDay)—For patients beginning warfarin therapy, proton pump inhibitor (PPI) co-therapy is associated with reduced risk of upper gastrointestinal bleeding, according to a study published in the December issue of Gastroenterology.

Zydus recalls single lot of blood thinner warfarin

June 12, 2013
Zydus Pharmaceuticals is recalling a single lot of the drug warfarin after receiving a complaint that some of the tablets are too large.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.